“…Steroids, composed of a complex cyclopentane-polyhydrophenanthrene structure, present anti-inflammatory and immunosuppressive effects and are used for treating various clinical diseases, including acute infections, inflammatory aftermath, autoimmune disorders of connective tissues, COVID-19, and acquired immunodeficiency syndrome (AIDS). , Introduction of the hydroxyl groups into the steroid backbone in a regioselective and stereoselective manner is an essential step for achieving ideal solubility as well as the physiological and pharmacological activity of steroids. − For instance, hydrocortisone, a typical corticosteroid with a progesterone (PG) skeleton and modified with three hydroxylations at C11β, C17α, and C21, possesses potent anti-inflammatory and immunosuppressive properties, making it an ideal choice for treating conditions such as allergies, dermatitis, and adrenal dysfunction. − Nevertheless, given the abundance of inert C–H bonds in steroids, achieving precise single or multiple oxidations of the steroid backbone without generating excess byproducts remains a formidable task in synthetic chemistry. , Thus, targeting the oxidation of steroid backbones to synthesize high-value steroidal pharmaceuticals in the process of producing hydroxyl-rich corticosteroids involves immense challenges such as numerous reaction steps, generation of substantial undesired byproducts, and elevated synthesis costs. , …”